Athira Pharma Inc (NASDAQ: ATHA) on Monday, plunged -8.77% from the previous trading day, before settling in for the closing price of $0.31. Within the past 52 weeks, ATHA’s price has moved between $0.22 and $3.67.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 75.66%. With a float of $33.69 million, this company’s outstanding shares have now reached $39.04 million.
The extent of productivity of a business whose workforce counts for 26 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Athira Pharma Inc (ATHA) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Athira Pharma Inc is 13.71%, while institutional ownership is 45.08%. The most recent insider transaction that took place on Jan 02 ’25, was worth 6,083. In this transaction CHIEF MEDICAL OFFICER of this company sold 10,826 shares at a rate of $0.56, taking the stock ownership to the 35,841 shares. Before that another transaction happened on Jan 02 ’25, when Company’s President and CEO sold 25,107 for $0.56, making the entire transaction worth $14,108. This insider now owns 242,591 shares in total.
Athira Pharma Inc (ATHA) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 75.66% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 62.77% during the next five years compared to -73.94% drop over the previous five years of trading.
Athira Pharma Inc (NASDAQ: ATHA) Trading Performance Indicators
Athira Pharma Inc (ATHA) is currently performing well based on its current performance indicators. A quick ratio of 7.26 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.07, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.43 in one year’s time.
Technical Analysis of Athira Pharma Inc (ATHA)
The latest stats from [Athira Pharma Inc, ATHA] show that its last 5-days average volume of 1.85 million was superior to 0.28 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 63.39%. Additionally, its Average True Range was 0.03.
During the past 100 days, Athira Pharma Inc’s (ATHA) raw stochastic average was set at 16.89%, which indicates a significant decrease from 46.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 77.77% in the past 14 days, which was higher than the 75.35% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2751, while its 200-day Moving Average is $0.6378. Now, the first resistance to watch is $0.3030. This is followed by the second major resistance level at $0.3209. The third major resistance level sits at $0.3351. If the price goes on to break the first support level at $0.2709, it is likely to go to the next support level at $0.2567. Assuming the price breaks the second support level, the third support level stands at $0.2388.
Athira Pharma Inc (NASDAQ: ATHA) Key Stats
Market capitalization of the company is 11.13 million based on 39,042K outstanding shares. Right now, sales total 0 K and income totals -96,940 K. The company made 0 K in profit during its latest quarter, and -9,140 K in sales during its previous quarter.
